Company page
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. is a public company traded under the ticker KYMR in the American market. The company has a market capitalization of approximately $7.44 billion. Kymera focuses on developing innovative therapeutics to address unmet medical needs.
- Ticker
- KYMR:NASDAQ
- Asset type
- Stock
- Market cap
- $7.44B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD